Share on StockTwits

Bio-Path Holdings (NASDAQ:BPTH) issued its quarterly earnings data on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Analyst Ratings News reports.

On a related note, analysts at Maxim Group initiated coverage on shares of Bio-Path Holdings in a research note on Monday, June 2nd. They set a “buy” rating and a $5.00 price target on the stock.

Bio-Path Holdings (NASDAQ:BPTH) opened at 2.24 on Monday. Bio-Path Holdings has a 52 week low of $0.46 and a 52 week high of $5.25. The stock’s 50-day moving average is $2.54 and its 200-day moving average is $3.03. The company’s market cap is $199.9 million.

Bio-Path Holdings, Inc (NASDAQ:BPTH) is a development-stage company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.